401 related articles for article (PubMed ID: 6754595)
1. Quantitative comparisons between carcinogenicity, mutagenicity and electrophilicity of direct-acting N-nitroso compounds and other alkylating agents.
Bartsch H; Malaveille C; Tomatis L; Brun G; Dodet B; Terracini B
IARC Sci Publ; 1982; (41):525-32. PubMed ID: 6754595
[TBL] [Abstract][Full Text] [Related]
2. Quantitative comparison of carcinogenicity, mutagenicity and electrophilicity of 10 direct-acting alkylating agents and of the initial O6:7-alkylguanine ratio in DNA with carcinogenic potency in rodents.
Bartsch H; Terracini B; Malaveille C; Tomatis L; Wahrendorf J; Brun G; Dodet B
Mutat Res; 1983 Aug; 110(2):181-219. PubMed ID: 6348521
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenicity and mutagenicity of N-nitroso compounds.
Lijinsky W
Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
[TBL] [Abstract][Full Text] [Related]
4. Mutagenicity studies in Salmonella typhimurium on some carcinogenic N-nitramines in vitro and in the host-mediated assay in rats.
Khudoley V; Malaveille C; Bartsch H
Cancer Res; 1981 Aug; 41(8):3205-10. PubMed ID: 7018677
[TBL] [Abstract][Full Text] [Related]
5. Biological and chemical properties of alkanediazotates as active species of N-nitroso compounds.
Ukawa S; Mochizuki M
IARC Sci Publ; 1991; (105):404-6. PubMed ID: 1855889
[TBL] [Abstract][Full Text] [Related]
6. Unexpected genetic toxicity to rodents of the N',N'-dimethyl analogues of MNU and ENU.
Tinwell H; Paton D; Guttenplan JB; Ashby J
Environ Mol Mutagen; 1996; 27(3):202-10. PubMed ID: 8625956
[TBL] [Abstract][Full Text] [Related]
7. Alkylation of DNA and carcinogenicity of N-nitroso compounds.
Montesano R; Pegg AE; Margison GP
J Toxicol Environ Health; 1980; 6(5-6):1001-8. PubMed ID: 6162032
[TBL] [Abstract][Full Text] [Related]
8. Bacterial-mammalian mutagenesis correlations: mechanistic significance for carcinogenesis.
Bartsch H
Ann N Y Acad Sci; 1983; 407():351-61. PubMed ID: 6576679
[TBL] [Abstract][Full Text] [Related]
9. Carcinogenicity and mutagenicity testing of three isomeric N-nitroso-N-methylaminopyridines in rats.
Preussmann R; Habs M; Pool BL
J Natl Cancer Inst; 1979 Jan; 62(1):153-6. PubMed ID: 364151
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by fatty acids of direct mutagenicity of N-nitroso compounds.
Takeda K; Ukawa S; Mochizuki M
IARC Sci Publ; 1991; (105):558-63. PubMed ID: 1855917
[TBL] [Abstract][Full Text] [Related]
11. Mutagenicity of isomeric alkanediazotates, precursors for ultimate alkylating species of carcinogenic N-nitroso compounds.
Ukawa-Ishikawa S; Sawada A; Kasuya K; Mochizuki M
Mutat Res; 1998 Jan; 412(1):99-107. PubMed ID: 9508369
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships in the mutagenicity of N-substituted derivatives of phenanthrene-9,10-imine.
Stark AA; Zeiger E; Shtelzer S; Sheradsky T; Lifshitz Y; Blum J
Mutagenesis; 1986 Jan; 1(1):35-9. PubMed ID: 3325734
[TBL] [Abstract][Full Text] [Related]
13. Quantitative relationship between mutagenic potency in the Ara test of Salmonella typhimurium and carcinogenic potency in rodents. A study of 11 direct-acting monofunctional alkylating agents.
Roldán-Arjona T; Luque-Romero FL; Ruiz-Rubio M; Pueyo C
Carcinogenesis; 1990 Jun; 11(6):975-80. PubMed ID: 2189599
[TBL] [Abstract][Full Text] [Related]
14. Mutagenic activity of chemical carcinogens and related compounds in the intraperitoneal host-mediated assay.
Simmon VF; Rosenkranz HS; Zeiger E; Poirier LA
J Natl Cancer Inst; 1979 Apr; 62(4):911-8. PubMed ID: 372659
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic and alkylating activities of 3-methyl-1-phenyltriazenes and their possible role as carcinogenic metabolites of the parent dimethyl compounds.
Malaveille C; Brun G; Kolar G; Bartsch H
Cancer Res; 1982 Apr; 42(4):1446-53. PubMed ID: 7060018
[TBL] [Abstract][Full Text] [Related]
16. Sites in nucleic acids reacting with alkylating agents of differing carcinogenicity of mutagenicity.
Singer B
J Toxicol Environ Health; 1977 Jul; 2(6):1279-95. PubMed ID: 328918
[TBL] [Abstract][Full Text] [Related]
17. Nucleophilic selectivity as a determinant of carcinogenic potency (TD50) in rodents: a comparison of mono- and bi-functional alkylating agents and vinyl chloride metabolites.
Barbin A; Bartsch H
Mutat Res; 1989 Nov; 215(1):95-106. PubMed ID: 2811916
[TBL] [Abstract][Full Text] [Related]
18. DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity.
Parodi S; De Flora S; Cavanna M; Pino A; Robbiano L; Bennicelli C; Brambilla G
Cancer Res; 1981 Apr; 41(4):1469-82. PubMed ID: 7214329
[TBL] [Abstract][Full Text] [Related]
19. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
Zeiger E
Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
[TBL] [Abstract][Full Text] [Related]
20. The results of assays in Drosophila as indicators of exposure to carcinogens.
Vogel EW; Graf U; Frei HJ; Nivard MM
IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
